Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Few things are more valuable in health care than data — specifically prescription data. Surescripts, a company that allows prescriptions to be filled electronically, controls a lot of that data and has every incentive to keep it gated.

Driving the news: Surescripts is asking the FBI to investigate allegations that one of its vendors illegally shared patients' medication histories with Amazon's online pharmacy, PillPack. It's a fight that highlights how difficult it has become for patients to share their own drug data and how incumbent players protect their turf.

How we got here: Surescripts contracted with a reseller called ReMy Health, which gave doctors, hospitals and other prescribers access to data on the drugs patients take or used to take.

Yes, but: Surescripts does not allow pharmacies to access medication history data. That means pharmacists, like those at PillPack, who want to verify someone's prescriptions have to spend the time calling and faxing doctors instead of going directly to Surescripts.

  • Here, Surescripts is alleging ReMy Health was sending that data to PillPack in violation of their contract and that PillPack was requesting data through providers who had never seen its patients.

Background: Surescripts has the backing of powerful players in today's drug supply chain and also has attracted attention for wielding its own market power.

  • Two of the largest pharmacy benefit managers, CVS and Express Scripts, as well as two trade groups representing drug stores own Surescripts.
  • SureScripts is facing a lawsuit from the Federal Trade Commission, which alleges Surescripts violated antitrust law by using its monopoly power to strong-arm pharmacies and other vendors into exclusively using its services.

"This action we are taking is purely and simply about maintaining trust on the network," Surescripts CEO Tom Skelton said in an interview, after being asked about how the firm's monopoly position factored into this dispute.

The other side: ReMy Health did not respond to requests for comment. A PillPack spokesperson said the company's patients give explicit consent to obtain medication histories.

  • "Given that Surescripts is, to our knowledge, the sole clearinghouse for medication history in the United States, the core question is whether Surescripts will allow customers to share their medication history with pharmacies and if not, why not?" PillPack said.

The bottom line: Something as simple as making sure someone is taking the right medications isn't that simple when there are billions of dollars up for grabs.

Go deeper

Janet Yellen confirmed as Treasury secretary

Janet Yellen. Photo: Alex Wong/Getty Images

The Senate voted 84-15 to confirm Janet Yellen as Treasury secretary on Monday.

Why it matters: Yellen is the first woman to serve as Treasury secretary, a Cabinet position that will be crucial in helping steer the country out of the pandemic-induced economic crisis.

Dan Primack, author of Pro Rata
3 hours ago - Economy & Business

Scoop: Red Sox strike out on deal to go public

Illustration: Sarah Grillo/Axios

The parent company of the Boston Red Sox and Liverpool F.C. has ended talks to sell a minority ownership stake to RedBall Acquisition, a SPAC formed by longtime baseball executive Billy Beane and investor Gerry Cardinale, Axios has learned from multiple sources. An alternative investment, structured more like private equity, remains possible.

Why it matters: Red Sox fans won't be able to buy stock in the team any time soon.